Filing Details

Accession Number:
0001209191-17-045945
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-07-21 16:20:40
Reporting Period:
2017-07-19
Filing Date:
2017-07-21
Accepted Time:
2017-07-21 16:20:40
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1131324 Genomic Health Inc GHDX Services-Medical Laboratories (8071) 770552594
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1649245 G. Phillip Febbo 301 Penobscot Dr.
Redwood City CA 94063
Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2017-07-19 2,844 $33.57 18,130 No 4 S Direct
Common Stock Disposition 2017-07-19 330 $33.57 17,800 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on May 15, 2017.
  2. Represents weighted average sale price. Actual sale prices ranged from $33.31 to $33.80.
  3. Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated.
  4. Includes an aggregate of 17,800 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
  5. Represents actual sale price.